Private equity is back in the hospice market though chasing a much smaller pool of assets than during the pandemic-era acquisition boom, according to industry sources. Lower borrowing costs, aging PE portfolios nearing exit windows, and renewed confidence from large deals have reignited a market that slowed sharply after the 2020-2021 surge, they said. “The rebound is being driven by both broader market conditions, including lower capital costs and stronger cash positions, as well as hospice-specific tailwinds such as stable reimbursement, a growing aging population, and increasing demand for home-based care,” said Robert Miller, partner at Hooper, Lundy & Bookman.
Read the full article: Hospice M&A Rebounds but Compliant Assets in Short Supply //
Source: https://ionanalytics.com/insights/mergermarket/hospice-ma-rebounds-but-compliant-assets-in-short-supply-dealspeak-north-america/